The Latest Breaking News from Ophthalmology

Optometrists are lobbying for more leeway to treat patients — and physicians' groups are pushing back. But it's more than a turf war, both sides say, as they explain why patients' vision is at stake.

Across the region, 20 hospital departments fail to give patients their first specialist appointment within 18 weeks

The improvements by the ophthalmology team at Ninewells Hospital are part of NHS Tayside’s Remobilisation Plan for services to recover from the effects of the pandemic

The field of optometry provides fertile grounds for raising costs, inviting private equity firm's investments

ST. LOUIS — Christina Green hoped cataract surgery would clear up her cloudy vision, which had worsened after she took a drug to fight her breast cancer.

The prevalence of eye diseases among soldiers led to the establishment of ‘Madras Eye Infirmary’ in July 1819 at Royapettah

Darrell Massie says he's been told he won't get in for a specialist appointment for 15 months, more than five times the state's clinically recommended time.

Immunovant Inc (NASDAQ:IMVT) has aligned with the FDA Division of Ophthalmology on plans to initiate two placebo-controlled Phase 3 trials to evaluate batoclimab in thyroid eye disease (TED).  Immunovant expects to initiate its Phase 3 TED program in 2H of 2022 and is expected to enroll about 100 subjects for each trial.  Topline…

Kala Pharmaceuticals Inc (NASDAQ:KALA) reported data from a Phase 1b trial of KPI-012, a cell-free secretome therapy for severe ocular diseases driven by impaired healing.  As previously disclosed, KPI-012 was well tolerated and resulted in significant improvements in various persistent corneal epithelial defect (PCED) etiologies.  The data will be presented at the 2022…